If you are wondering whether Medtronic's current share price still offers value, this article will walk through what that ...

Bernstein analyst Lee Hambright maintained a Buy rating on Medtronic today and set a price target of $112.00. According to TipRanks, Hambright is a 4-star analyst with an average return of 8.1% and a ...

Fintel reports that on January 6, 2026, William Blair upgraded their outlook for Medtronic (NYSE:MDT) from Market Perform to ...

Medtronic (MDT) is back in focus after William Blair upgraded the stock to Outperform, highlighting new product ramps tied to ...

Investors looking for stocks in the Medical - Products sector might want to consider either Medtronic (MDT) or EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks presents ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Medtronic on January 7 and set a price target of $118.00. The company’s shares closed yesterday at $99.77.

Medtronic (MDT) is a strong defensive investment with stable growth, 49 years of dividend increases, and fair value. Read here for more analysis.

TheFly reported on December 18 that Truist Securities maintained its Hold recommendation on MDT but lowered its price ...

William Blair upgraded Medtronic, citing new product launches, FDA approvals, improving valuation, and clearer growth drivers ...

The CUSO hosted its 2025 MDT E3 Conference, convening nearly 300 credit union executives and technology leaders to collaborate, learn and advance innovation shaping the credit union landscape. The ...

In one of his recent videos, University of Chicago political science professor John Mearsheimer, author of The Tragedy of ...

It has been about a month since the last earnings report for Medtronic (MDT). Shares have lost about 2% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the ...